Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Keytruda
Pharma
Merck scores FDA approval for subcutaneous Keytruda
Merck plans to launch Keytruda Qlex soon despite an ongoing patent dispute with Halozyme.
Angus Liu
Sep 19, 2025 4:54pm
Big Pharma bounces back in Q2
Aug 22, 2025 9:09am
Roche touts Tecentriq biomarker win in bladder cancer
Aug 18, 2025 4:17pm
AZ, Genentech, Merck top oncology HCP promotions: report
Aug 14, 2025 11:52am
Merck eliminates 58 jobs in NJ as part of cost-cutting plan
Aug 13, 2025 9:42am
Padcev-Keytruda combo delivers bladder cancer 'breakthrough'
Aug 12, 2025 11:16am
